Trial Profile

A Randomized, Open-label, Single Dose, Crossover Study to Compare the Pharmacokinetic Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 (1000/10mg) in Healthy Male Volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 18 Sep 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Metformin/rosuvastatin (Primary) ; Metformin; Rosuvastatin
Indications Cardiovascular disorders; Dyslipidaemias; Type 2 diabetes mellitus
Focus Pharmacokinetics
Sponsors Jeil Pharmaceutical

27 Mar 2019 Status changed from recruiting to completed.
14 Nov 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Oct 2018 to 1 Dec 2018.
25 Oct 2018 Status changed from not yet recruiting to recruiting.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com